Average Co-Inventor Count = 7.49
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Takeda Pharmaceutical Company Limited (21 from 1,177 patents)
2. Cardurion Pharmaceuticals, LLC (4 from 10 patents)
3. Patcore, Inc. (1 from 4 patents)
4. Endosome Therapeutics, Inc. (1 from 1 patent)
26 patents:
1. 11851449 - Heterocyclic amide compounds having an RORvt inhibitory action
2. 11795172 - Substituted imidazo[1,2-b]pyridazines and [1,2,4]triazolo[4,3-b]pyridazines as CaMKII inhibitors
3. RE49686 - Nitrogen-containing heterocyclic compound and use of same
4. 11495331 - Document creation assistance server and document creation assistance method
5. 11324832 - Tripartite modulators of endosomal G protein-coupled receptors
6. 11197858 - Substituted amines for treating cardiac diseases
7. 11130752 - Aminopyrimidine compound
8. 11053262 - Heterocyclic amide compounds having RORyT inhibitory action
9. RE48334 - Nitrogen-containing heterocyclic compound and use of same
10. 10543212 - Substituted amines for treating cardiac diseases
11. 10472376 - Amide compound
12. 10093629 - Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitors
13. 10053468 - Heterocyclic compound
14. 10000488 - Heterocyclic compound
15. 9834520 - Heterocyclic compound